Jump to Section

Choosing the right medication for opioid use disorder treatment can shape the entire recovery process. Among the most widely used options today are Vivitrol and Sublocade—both FDA-approved medications designed to support long-term sobriety and prevent relapse. While they share a common goal, they work in very different ways within the brain and body.

Understanding the key differences between Vivitrol and Sublocade is essential for patients, families, and healthcare professionals developing an effective treatment plan. This article breaks down how each medication works, its benefits, limitations, and how they fit into modern medication-assisted treatment.

Understanding Opioid Use Disorder

Opioid use disorder is a chronic condition involving both physical dependence and mental dependence on opioids. These substances interact with opioid receptors in the brain, producing pain relief and euphoric effects. Over time, repeated use alters brain chemistry, leading to opioid cravings and compulsive use despite harmful consequences.

According to the Substance Abuse and Mental Health Services Administration, over 6 million people in the United States live with opioid use disorder.[1] The Centers for Disease Control and Prevention reports that more than 80,000 opioid-related overdose deaths occur annually, highlighting the urgent need for effective addiction treatment.[2]

Medication-assisted treatment (MAT) is considered the gold standard for treating substance use disorders, combining medication with behavioral therapy and mental health support.

What Is Vivitrol?

Vivitrol is an extended-release injectable suspension containing the active ingredient naltrexone. It is classified as an opioid antagonist, meaning it blocks opioid receptors rather than activating them.

How Vivitrol Works

Vivitrol binds to opioid receptors and prevents other opioids from producing euphoric effects. This helps:[3]

Reduce cravings
Prevent relapse
Block the effects of illicit opioid use

Because it blocks opioid effects entirely, patients must be fully opioid free before starting vivitrol treatment. This requires completing a full detox, typically 7–10 days without opioids.

Key features of Vivitrol to be aware of:

Monthly injection administered by a healthcare professional
Non-addictive
Also approved for alcohol use disorder and alcohol dependence
No opioid agonist activity

Vivitrol is often used for individuals who have already completed opioid detox and want a medication that supports abstinence without ongoing opioid exposure.

What Is Sublocade?

Sublocade is an injectable form of buprenorphine extended release. It is classified as a partial opioid agonist, meaning it activates opioid receptors but in a limited way.

How Sublocade Works

Sublocade delivers a steady level of buprenorphine over time, which helps:[4]

Reduce cravings
Minimize withdrawal symptoms
Stabilize brain chemistry

Unlike full opioid agonists, buprenorphine produces limited euphoric effects, lowering the risk of misuse.

Key features of Sublocade that you should be aware of include:

Monthly injection
Contains buprenorphine extended release
Must begin after stabilization on oral buprenorphine
Supports treatment retention

Sublocade is often used during the maintenance phase of recovery, especially for individuals with ongoing opioid dependence.

Vivitrol vs Sublocade: Key Differences

The comparison of Sublocade vs. Vivitrol comes down to how each medication interacts with opioid receptors and where it fits in the recovery journey.

Mechanism of Action

Vivitrol is an opioid antagonist, which means it blocks opioid receptors. On the other hand, Sublocade is a partial opioid agonist, meaning it partially activates opioid receptors.

This is one of the most important distinctions. Vivitrol prevents any opioid effect, while Sublocade reduces cravings by partially stimulating receptors.

Detox Requirements

Vivitrol requires full detox and opioid-free status before beginning treatment. In contrast, Sublocade can be started after transitioning from oral buprenorphine.

This makes Sublocade more accessible for individuals who struggle with the detox phase.

Risk of Misuse

Vivitrol has no misuse potential, while Sublocade has a lower misuse risk than full agonists but is still an opioid-based medication.

Treatment Goals

Vivitrol is intended to support complete abstinence. Sublocade is designed to support stabilization and gradual recovery.

Effectiveness and Treatment Outcomes

Both sublocade and vivitrol have been shown to improve treatment retention and reduce relapse rates when used as part of a comprehensive treatment plan.

A study published in The Lancet Psychiatry found that buprenorphine-based treatments like Sublocade significantly improve retention compared to antagonist-based treatments.[5] However, Vivitrol is equally effective for individuals who complete detox.

According to the National Institute on Drug Abuse:[6]

MAT reduces opioid misuse by up to 75%
It lowers overdose risk by more than 50%
It improves long-term sobriety outcomes

The choice between Vivitrol vs. Sublocade often depends on individual medical history, treatment goals, and readiness for detox.

Side Effects and Safety Considerations

Vivitrol Side Effects

The side effects of Vivitrol may include:

Nausea
Headache
Injection site reactions
Low blood pressure (rare)

Because Vivitrol blocks opioids, attempting to override it with high doses of opioids can increase overdose risk.

Sublocade Side Effects

The side effects of Sublocade may include:

Constipation
Fatigue
Injection site reactions
Mild opioid effects

Since Sublocade is a partial opioid agonist, it may still cause mild opioid effects, but at a controlled level.

Both medications require medical supervision and should only be administered by a qualified healthcare professional.

Role in Medication-Assisted Treatment

Medication-assisted treatment is not just about medication—it includes behavioral therapy, counseling, and ongoing support.

Vivitrol in MAT

Vivitrol is often used for individuals who:

Have completed opioid detox
Want to remain completely opioid free
Are motivated toward a substance-free life

Sublocade in MAT

Sublocade is often recommended for those who:

Experience strong withdrawal symptoms
Need help stabilizing medication levels
Benefit from the gradual reduction of opioid dependence

Both options are effective when combined with therapy and mental health services.

Cost and Insurance Coverage

Cost can be a deciding factor when comparing Sublocade and Vivitrol. For example, these medications may cost:

Vivitrol: Approximately $1,000–$1,500 per injection
Sublocade: Approximately $1,500–$2,000 per injection

Many insurance plans, including those under the Affordable Care Act, cover medication-assisted treatment. Coverage varies, so verifying health insurance benefits is important.

Choosing the Right Option

Selecting between vivitrol and sublocade depends on several factors:

Consider Vivitrol If:

You have completed full detox
You want zero opioid exposure
You are treating alcohol use disorder as well

Consider Sublocade If:

You are still experiencing withdrawal symptoms
You need help managing cravings
You are transitioning from another medication

A healthcare professional will evaluate your medical history, substance use patterns, and treatment goals before recommending a medication.

The Importance of a Comprehensive Treatment Plan

Medication alone is not enough for lasting recovery. A successful treatment plan should include:

Behavioral therapy
Mental health support
Relapse prevention strategies
Ongoing monitoring

Addiction medicine emphasizes treating the whole person—not just the substance use disorder.

Preventing Relapse and Supporting Long-Term Recovery

Both Vivitrol and Sublocade treatment options are designed to prevent relapse and support long-term sobriety. However, success depends on consistent treatment adherence and support systems.

Recovery is not a single event but a recovery journey that evolves. Medication can stabilize the body, but therapy and lifestyle changes sustain progress.

Get Connected to Medication-Assisted Treatment Near You

The choice between Vivitrol vs. Sublocade is not about which medication is “better,” but which is more appropriate for a specific individual.

Vivitrol offers a non-opioid approach that blocks opioid effects entirely, making it ideal for those who have completed detox and want to remain opioid free. Sublocade, on the other hand, provides a steady, controlled opioid effect that reduces cravings and withdrawal symptoms, supporting individuals earlier in the recovery process.

Both medications are powerful tools in modern opioid use disorder treatment. When combined with behavioral therapy and medical supervision, they can significantly improve outcomes and help individuals move toward a stable, substance-free life.

Contact Mandala Healing Center today to learn more about whether Sublocade or Vivitrol is right for you.

Frequently Asked Questions (FAQ)

1. How long do Vivitrol and Sublocade stay in your system?

Both medications are designed as a monthly injection, but their effects can last beyond 30 days. Vivitrol (active ingredient naltrexone) typically blocks opioid receptors for about 28 days, while Sublocade (buprenorphine extended release) maintains stable medication levels for a full month and can remain detectable in the body for several weeks afterward. The exact duration varies based on metabolism, dosage, and overall medical history.

2. Can you switch between Vivitrol and Sublocade?

Yes, but switching requires careful medical supervision. Moving from Sublocade to Vivitrol requires a full detox period to ensure the body is opioid free before starting an opioid antagonist. Transitioning in the opposite direction may involve starting oral buprenorphine before receiving Sublocade. A healthcare professional will determine the safest approach based on your treatment plan and recovery goals.

3. Which medication is better for preventing relapse?

Both medications are effective at helping prevent relapse, but they work differently. Vivitrol blocks the effects of other opioids entirely, which can discourage opioid misuse. Sublocade reduces cravings and stabilizes brain chemistry, making it easier to avoid illicit opioid use. The best option depends on individual factors such as treatment adherence, history of relapse, and stage in the recovery process.

4. Are these medications safe during pregnancy?

Sublocade and other forms of buprenorphine are sometimes used during pregnancy under strict medical supervision, as they can help manage opioid dependence safely. Vivitrol is less commonly recommended during pregnancy due to limited research on its effects. Anyone who is pregnant or planning to become pregnant should discuss all treatment options with a qualified healthcare professional.

5. Do Vivitrol or Sublocade interact with other medications?

Yes, both can interact with other medications. Vivitrol may interfere with opioid-based pain relief, making standard pain management less effective. Sublocade, as a partial opioid agonist, can interact with sedatives or other central nervous system depressants, increasing the risk of side effects. Always disclose all prescriptions, supplements, and substance use to your provider.

6. What happens if you miss a monthly injection?

Missing a dose can reduce the effectiveness of treatment and increase the risk of opioid cravings or relapse. For Vivitrol, the protective opioid blockade may wear off. For Sublocade, medication levels may drop below the therapeutic range. If a dose is missed, it’s important to contact your healthcare professional as soon as possible to resume treatment safely and maintain progress in your recovery journey.

References: